↓ Skip to main content

Neuroepigenomics in Aging and Disease

Overview of attention for book
Cover of 'Neuroepigenomics in Aging and Disease'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome
  3. Altmetric Badge
    Chapter 2 The Role of Noncoding RNAs in Neurodevelopmental Disorders: The Case of Rett Syndrome
  4. Altmetric Badge
    Chapter 3 Rubinstein-Taybi Syndrome and Epigenetic Alterations
  5. Altmetric Badge
    Chapter 4 Epigenetics of Autism Spectrum Disorder
  6. Altmetric Badge
    Chapter 5 Eating Disorders and Epigenetics
  7. Altmetric Badge
    Chapter 6 Drug Addiction and DNA Modifications
  8. Altmetric Badge
    Chapter 7 Drug Addiction and Histone Code Alterations
  9. Altmetric Badge
    Chapter 8 Anxiety and Epigenetics
  10. Altmetric Badge
    Chapter 9 Histone Modifications in Major Depressive Disorder and Related Rodent Models
  11. Altmetric Badge
    Chapter 10 DNA Methylation in Major Depressive Disorder
  12. Altmetric Badge
    Chapter 11 Noncoding RNAs in Depression
  13. Altmetric Badge
    Chapter 12 DNA Methylation in Schizophrenia
  14. Altmetric Badge
    Chapter 13 Histone Posttranslational Modifications in Schizophrenia
  15. Altmetric Badge
    Chapter 14 Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis
  16. Altmetric Badge
    Chapter 15 Epigenetics of Huntington’s Disease
  17. Altmetric Badge
    Chapter 16 DNA Modifications and Alzheimer’s Disease
  18. Altmetric Badge
    Chapter 17 Alzheimer’s Disease and Histone Code Alterations
  19. Altmetric Badge
    Chapter 18 Alzheimer’s Disease and ncRNAs
  20. Altmetric Badge
    Chapter 19 Epigenetics in Parkinson’s Disease
  21. Altmetric Badge
    Chapter 20 Single-Cell Genomics Unravels Brain Cell-Type Complexity
  22. Altmetric Badge
    Chapter 21 Epigenome Editing in the Brain
  23. Altmetric Badge
    Chapter 22 Techniques for Single-Molecule mRNA Imaging in Living Cells
  24. Altmetric Badge
    Chapter 23 Stem Cell Technology for (Epi)genetic Brain Disorders
  25. Altmetric Badge
    Chapter 24 Technologies for Deciphering Epigenomic DNA Patterns
  26. Altmetric Badge
    Chapter 25 Bioinformatics Tools for Genome-Wide Epigenetic Research
Attention for Chapter 3: Rubinstein-Taybi Syndrome and Epigenetic Alterations
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Rubinstein-Taybi Syndrome and Epigenetic Alterations
Chapter number 3
Book title
Neuroepigenomics in Aging and Disease
Published in
Advances in experimental medicine and biology, May 2017
DOI 10.1007/978-3-319-53889-1_3
Pubmed ID
Book ISBNs
978-3-31-953888-4, 978-3-31-953889-1
Authors

Korzus, Edward, Edward Korzus Ph.D., Edward Korzus

Editors

Raul Delgado-Morales

Abstract

Rubinstein-Taybi syndrome (RSTS) is a rare genetic disorder in humans characterized by growth and psychomotor delay, abnormal gross anatomy, and mild to severe mental retardation (Rubinstein and Taybi, Am J Dis Child 105:588-608, 1963, Hennekam et al., Am J Med Genet Suppl 6:56-64, 1990). RSTS is caused by de novo mutations in epigenetics-associated genes, including the cAMP response element-binding protein (CREBBP), the gene-encoding protein referred to as CBP, and the EP300 gene, which encodes the p300 protein, a CBP homologue. Recent studies of the epigenetic mechanisms underlying cognitive functions in mice provide direct evidence for the involvement of nuclear factors (e.g., CBP) in the control of higher cognitive functions. In fact, a role for CBP in higher cognitive function is suggested by the finding that RSTS is caused by heterozygous mutations at the CBP locus (Petrij et al., Nature 376:348-351, 1995). CBP was demonstrated to possess an intrinsic histone acetyltransferase activity (Ogryzko et al., Cell 87:953-959, 1996) that is required for CREB-mediated gene expression (Korzus et al., Science 279:703-707, 1998). The intrinsic protein acetyltransferase activity in CBP might directly destabilize promoter-bound nucleosomes, facilitating the activation of transcription. Due to the complexity of developmental abnormalities and the possible genetic compensation associated with this congenital disorder, however, it is difficult to establish a direct role for CBP in cognitive function in the adult brain. Although aspects of the clinical presentation in RSTS cases have been extensively studied, a spectrum of symptoms found in RSTS patients can be accessed only after birth, and, thus, prenatal genetic tests for this extremely rare genetic disorder are seldom considered. Even though there has been intensive research on the genetic and epigenetic function of the CREBBP gene in rodents, the etiology of this devastating congenital human disorder is largely unknown.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 17%
Student > Ph. D. Student 6 13%
Researcher 5 10%
Student > Bachelor 4 8%
Student > Doctoral Student 2 4%
Other 7 15%
Unknown 16 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 21%
Medicine and Dentistry 9 19%
Neuroscience 6 13%
Nursing and Health Professions 3 6%
Agricultural and Biological Sciences 2 4%
Other 1 2%
Unknown 17 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 May 2017.
All research outputs
#14,562,219
of 23,321,213 outputs
Outputs from Advances in experimental medicine and biology
#2,143
of 4,993 outputs
Outputs of similar age
#175,841
of 313,723 outputs
Outputs of similar age from Advances in experimental medicine and biology
#48
of 106 outputs
Altmetric has tracked 23,321,213 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,993 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,723 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 106 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.